Beam Therapeutics Inc. - BEAM

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 26, 2026 SCHEDULE 13G/A The Vanguard Group 0.0% 0 View
Feb 05, 2026 SCHEDULE 13G/A FMR LLC 12.6% 12,750,369 View
Feb 05, 2026 SCHEDULE 13G/A Abigail P. Johnson 12.6% 12,750,369 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Capital Partners, L.P. 0.7% 688,623 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Capital Institutional Partners, L.P. 0.8% 836,691 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Capital Institutional Partners II, L.P. 0.2% 233,233 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Capital Institutional Partners III, L.P. 0.1% 104,266 View
Feb 05, 2026 SCHEDULE 13G/A Four Crossings Institutional Partners V, L.P. 0.1% 150,101 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Capital Offshore Investors II, L.P. 1.6% 1,632,718 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Capital (AM) Investors, L.P. 0.1% 94,237 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Capital F5 Master I, L.P. 0.3% 333,253 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Healthcare Partners Master, L.P. 6.0% 6,068,735 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Partners, L.L.C. 9.7% 9,808,603 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Institutional (GP) V, L.L.C. 0.1% 150,101 View
Feb 05, 2026 SCHEDULE 13G/A Farallon F5 (GP), L.L.C. 0.3% 333,253 View
Feb 05, 2026 SCHEDULE 13G/A Farallon Healthcare Partners (GP), L.L.C. 6.0% 6,068,735 View
Feb 05, 2026 SCHEDULE 13G/A Dapice Joshua J. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Dreyfuss, Philip D. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Dunn Hannah E. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Fried, Richard B 0.0% 0 View
Feb 05, 2026 SCHEDULE 13G/A Gehani, Varun N. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Giauque, Nicolas 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Husen, Avner A. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Kim, David T. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Linn, Michael G. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Luo Patrick (Cheng) 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Patel, Rajiv A. 0.0% 0 View
Feb 05, 2026 SCHEDULE 13G/A Roberts, Jr., Thomas G. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Saito Edric C. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Seybold, William 0.0% 0 View
Feb 05, 2026 SCHEDULE 13G/A Short Daniel S. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Spokes, Andrew J. M. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Warren, John R. 9.99% 10,141,856 View
Feb 05, 2026 SCHEDULE 13G/A Wehrly, Mark C. 9.99% 10,141,856 View
Feb 03, 2026 SCHEDULE 13G/A ARK Investment Management LLC 12.29% 12,467,189 View
Feb 03, 2026 SCHEDULE 13G/A Catherine D. Wood 12.29% 12,467,189 View
Nov 05, 2025 SCHEDULE 13G/A FMR LLC 13.6% 13,766,518 View
Nov 05, 2025 SCHEDULE 13G/A Abigail P. Johnson 13.6% 13,766,518 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.